Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Alcohol-associated Liver Disease
How do you incorporate addiction medicine and counseling into your treatment plan for patients with alcohol associated liver disease?
Related Questions
What factors into your choice to use craving-related medications (e.g., baclofen, naltrexone, acamprosate, etc.) in the management of alcohol use disorder?
How do you approach a conversation with a patient with a markedly positive PETH (>200 ug/L) who is insistent that they do not consume any alcohol?
With the growth of non-alcoholic beverages (e.g., NA beer, liquor, etc), how do you approach a patient's consumption of these products in the setting of alcohol related liver disease?
How has the move away from a strict 6 month period of sobriety impacted your patient selection criteria for transplant of patients with alcohol associated liver disease?
All things being equal, what patient factors are you looking at in the selection of TAF or TDF in the management of hepatitis B?
What is your approach to treatment of immune-mediated overlap syndromes, such as AIH-PBC?
For how long would you treat a patient with latent TB before allowing them to proceed with a liver transplant?
How do you prefer to manage IgG-4 related hepato-biliary disease, especially if there are similarities in imaging findings to other immune mediated liver diseases?
How much do you factor in a patient's frailty in selection for transplant if the underlying driver for their debility is their underlying liver disease itself?
How does managing a patient with concomitant alcohol related liver disease impact your choice of therapies?
